We provide the solution for clients in need of high quality research and testing of their products in Indonesia. MRIN-ACRO is a Contract Research Organization  with strong academic background that will provide a range of service pertaining to translational studies, pre-clinical feasibility, efficacy, safety and other  regulatory-based tests to meet national and international standards.

Equipped with advanced laboratory and animal facility, MRIN-ACRO offers in-vitro and in-vivo service platforms that can be tailored to clients' need. The barrier animal facility will allow for acquisition and maintenance of SPF rodent models, which are pre-requisite for assurance of validity and reproducibility. As part of the UPH Medical Science Group, MRIN-ACRO serves as a unique hub for bench-to-bedside translational studies.

In addition to serving projects tailored to client's research and testing purposes, MRIN Animal research facility is well-experienced in provision of animal model for cancer and diabetic studies. Comprehensive sample collection may be performed to allow various assessments such as blood chemistry, hematology, and molecular markers. Animal research facility is directly supported by the Pathology division with the ability to investigate the mechanism for development and progression of various disease (cancer and diabetic) from anatomical, histological, and molecular biological points of view;

1.  From anatomical point of view, lesions can be compared by gross anatomy.

2.  From histological point of view, cell structures can be evaluated with appropriate staining methods.

3.  From molecular pathology point of view, transcript and/or protein from blood and tissues can be analyzed with methods such as ELISA, Western Blot, 

     RT-PCR, qPCR, and immunohistochemistry.

For more information, please contact us:

mrin.acro@mrinstitute.org

MRIN-ACRO